Gemtesa 75 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F96X9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,160
Award facts
- Contract value 100% obligated
- $2,160.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,160.06 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (30-count supply) on January 12, 2026, with an ultimate completion date of January 13, 2026. This non-set-aside, competitively awarded contract utilized firm fixed-price pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a major pharmaceutical distributor serving federal medical procurement needs across the military and veteran healthcare systems.
This delivery order is executed under a larger Indefinite Delivery Contract vehicle—the DLA Troop Support Medical Pharmaceutical Prime Vendor agreement (SPE2DX)—valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC enables AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The company's federal contract portfolio demonstrates consistent capability to meet DLA requirements through open competition and efficient fulfillment of essential pharmaceutical commodities for military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F96X9?
SPE2DR26F96X9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F96X9 worth?
The government has obligated $2,160 on SPE2DR26F96X9.
Is contract SPE2DR26F96X9 an order under another contract?
Yes. SPE2DR26F96X9 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F96X9 competed?
The extent of competition for SPE2DR26F96X9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award